Navigation Links
Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results
Date:2/29/2008

hts* (20,000) (1,150)

Branded License Fees and Premium

Paid on Equity Investments 19,150 -

Stock Option Tender Offer 4,615 -

Severance Costs 1,643 12,373

Net Investment Loss 1,584 583

Gain on Settlement (578) 1,502

Write-off of Accounts Receivable

Relating to Invalid

Customer Deductions - 9,965

Asset Impairment - 1,000

Estimated Tax on Adjustments (2,437) (9,466)

Adjusted Income from Continuing

Operations (non-GAAP measure) $55,087 $21,548

Diluted Earning Per Share from

Continuing Operations:

Reported $1.47 $0.19

Adjusted (non-GAAP measure) $1.59 $0.62

*2006 amounts represent $3,054 gain on sale of product rights net of $1,904 loss on the return of inventory from a customer relating to the same agreement.


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008
2. China Sky One Medical, Inc. to Acquire Heilongjiang Tianlong Pharmaceutical, Inc.
3. MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results
4. KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis
5. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
6. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
7. VIA Pharmaceuticals to Present at Susquehanna and Rodman & Renshaw Conferences on March 4, 2008
8. Lotus Pharmaceuticals Raises $5 Million in Private Placement
9. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
10. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
11. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... San Mateo, Calif. (PRWEB) May 06, 2015 ... SafeMonk today announced a strategic partnership to ... in the cloud. The two industry-leading companies are teaming ... encryption platform. , “We’re thrilled to welcome ... meaningful to us that the people behind SafeMonk, the ...
(Date:5/6/2015)... Aging2.0 - the global network ... lineup of speakers and sponsors for its second annual ... for May 18-19 in San Francisco, brings together a ... investors and more than 50 startups from around the ... new products and services for the aging population. ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 In celebration of ... wigs giveaway. Every month they will give away a deluxe ... They listed a few steps to enter on a third-party ... at random, so anyone can be the winner. , The ... PremierLaceWigs.com has been the destination for such a jewel for ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 The American ... nomination period for its prestigious Integrated Water Resources Management ... IWRM approach to water resources projects. , An IWRM approach ... our establishment in 1964. In 2014, 12 projects were nominated ... IMPACT magazine features not only the 2014 AWRA IWRM Award ...
(Date:5/6/2015)... May 06, 2015 The Jefferson ... dedicated to activating and celebrating public service, announced ... Highmark Health, as an Outstanding Employee Volunteer Organization. ... Jefferson Awards Foundation, are dedicated to building a ... a decade, Highmark Health has recognized employees who ...
Breaking Medicine News(10 mins):Health News:Sookasa Grows Globally With SafeMonk Partnership 2Health News:Sookasa Grows Globally With SafeMonk Partnership 3Health News:Aging2.0 Global Innovation Summit Provides Unique Forum to Discover New Technologies and Develop Partnerships in the Senior Care Market 2Health News:Aging2.0 Global Innovation Summit Provides Unique Forum to Discover New Technologies and Develop Partnerships in the Senior Care Market 3Health News:Aging2.0 Global Innovation Summit Provides Unique Forum to Discover New Technologies and Develop Partnerships in the Senior Care Market 4Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:The Jefferson Awards Foundation Honors Highmark Health 2Health News:The Jefferson Awards Foundation Honors Highmark Health 3Health News:The Jefferson Awards Foundation Honors Highmark Health 4
... DCM is a condition which occurs when the heart becomes ... blood efficiently. The condition affects 35 in every 100,000 people. ... study published in the journal Science that a defect in ... key role in regulating the flow of calcium through the ...
... the Johns Hopkins School of Public Health has caused concerns ... urgent research into the impact of soya on unborn children ... can damage the male reproductive organs. Though there is no ... its effects on rats were so severe that// researchers believe ...
... in blood has been believed to be the ... of heart disease is associated with increased levels ... between LDL(Low-Density Lipoprotein)or 'bad' cholesterol and HDL(High-Density Lipoprotein) ... However, researchers in Canada and Sweden are now ...
... killers and both in developed and developing countries heart ... lost - through premature death and disability. Researchers at ... of measures that could reduce the number of years ... measures could be divided// into non-personal and personal. Non-personal ...
... ghrelin, has been identified by researchers from the Oregon ... of the hormone on the brain and have shown ... hypothalamus involved in weight regulation. Ghrelin is a hormone ... feeding when introduced to specialized weight regulating brain cells ...
... A recent study by researchers at the University of Durham ... benefit to the long list of already existing ones, for ... are at much less risk of being smothered than babies ... and their babies who were filmed at night while they ...
Cached Medicine News:Health News:Scientists locate key hormone involved in appetite control 2
(Date:5/6/2015)... AVIV, Israel , May 6, 2015  Galmed ... biopharmaceutical company focused on the development and commercialization of ... diseases and cholesterol gallstones, announced today that it will ... 13, 2015 to discuss results for the period ended ... current developments with respect to its clinical program for ...
(Date:5/6/2015)... , May 6, 2015 Neuralstem, Inc. (NYSE ... technology to develop small molecule and cell therapy treatments ... Jonathan Lloyd Jones to the position of ... Mr. Lloyd Jones brings to ... and business development experience.   Most recently, Mr. Lloyd ...
(Date:5/6/2015)... BOSTON, May 6, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: ... financial results for the three-month period ended March 31, ... were $8.3 million, an increase of 19% as compared ... , Product revenues increased 41% year-over-year, enabled by ... shipments to Merck Serono in the fourth quarter of ...
Breaking Medicine Technology:Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 2Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 3Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 5Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 6Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 7Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 8Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 9Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 10Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 11
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Inquire...
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
... The new Finnpipette Focus ... specifically to combine ergonomics with ... interchangeable handle plate offers a ... sizes. The new shorter tip ...
Medicine Products: